AbCellera to Report Full Year 2022 Financial Results on February 21, 2023

Rhea-AI Summary

AbCellera (NASDAQ: ABCL) will disclose its full year 2022 financial results on February 21, 2023, during a conference call at 2:00 p.m. PT (5:00 p.m. ET). A live audio webcast will be available on AbCellera's Investor Relations website, with a replay following the event. AbCellera is a biotechnology firm that focuses on identifying antibodies through the analysis of natural immune systems, aiding drug developers in creating treatments for various diseases. The company's partnerships span large pharmaceutical firms to small biotechs, enhancing efficiency in drug development.

Positive

• Upcoming earnings call could indicate positive revenue metrics for 2022.
• AbCellera’s technology supports rapid drug development, which may lead to increased partnerships.

Negative

• None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its full year 2022 financial results on Tuesday, February 21, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005747/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When will AbCellera announce its 2022 financial results?

AbCellera will announce its 2022 financial results on February 21, 2023.

What time is AbCellera's earnings conference call?

The earnings conference call will be held at 2:00 p.m. Pacific Time on February 21, 2023.

Where can I listen to AbCellera's earnings call?

You can listen to the earnings call on AbCellera's Investor Relations website.

What does AbCellera specialize in?

AbCellera specializes in finding antibodies by analyzing natural immune systems to assist drug developers.